Mark K. Wedel

Potent Reduction of Apolipoprotein B and Low-Density Lipoprotein Cholesterol by Short-Term Administration of an Antisense Inhibitor of Apolipoprotein B

John J.P. Kastelein, Mark K. Wedel, Brenda F. Baker et al. · Circulation · 2006 · 357 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Partial Liquid Ventilation in Adult Patients with Acute Respiratory Distress Syndrome

Robert M. Kacmarek, Herbert Wiedemann, Philip T. Lavin et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 165 citations

Medicine, Internal Medicine, Pulmonology +11

Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

Fatima Akdim, Erik S.G. Stroes, Eric J.G. Sijbrands et al. · Journal of the American College of Cardiology · 2010 · 161 citations

Pharmacy, Pharmacology, Pharmacotherapy +13

An enema formulation of alicaforsen, an antisense inhibitor of intercellular adhesion molecule‐1, in the treatment of chronic, unremitting pouchitis

Philip B. Miner, Mark K. Wedel, Barbara L. Bane et al. · Alimentary Pharmacology & Therapeutics · 2004 · 137 citations · Full text

Pharmacy, Pharmacotherapy, Surgery +17

A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis

Sander J. H. van Deventer, Mark K. Wedel, Brenda F. Baker et al. · Alimentary Pharmacology & Therapeutics · 2006 · 126 citations

Nursing, Pharmacology, Pharmacotherapy +17